Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 2, 2007, Pages 681-691

  Qi, Xiaoping ^a   Lewin, Alfred S ^a   Sun, Liang ^a   Hauswirth, William W ^a   Guy, John ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERIUM CHLORIDE; DICHLOROFLUORESCEIN DIACETATE; DYE; GREEN FLUORESCENT PROTEIN; HYDROETHIDINE; MANGANESE SUPEROXIDE DISMUTASE; PARVOVIRUS VECTOR; REACTIVE OXYGEN METABOLITE; RIBOZYME; UNCLASSIFIED DRUG; FLUORESCENT DYE; SUPEROXIDE DISMUTASE;

ADENO ASSOCIATED VIRUS; ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; MITOCHONDRION; MOUSE; MYELINATION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NEURITIS; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; VIRAL GENE DELIVERY SYSTEM; ALLERGIC ENCEPHALOMYELITIS; ANIMAL; CULTURE TECHNIQUE; DBA MOUSE; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; MYELIN SHEATH; PATHOLOGY;

ANIMALS; CELL CULTURE TECHNIQUES; DEPENDOVIRUS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GENE THERAPY; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED DBA; MITOCHONDRIA; MYELIN SHEATH; OPTIC NERVE; OPTIC NEURITIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINAL GANGLION CELLS; RNA, CATALYTIC; SUPEROXIDE DISMUTASE; TRANSFECTION;

EID: 33847701239     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0553     Document Type: Article

References (53)

1. Baker D, Hankey DJ. Gene therapy in autoimmune, demyelinating disease of the central nervous system. Gene Ther. 2003;10:844-853.
2. Owens T. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol. 2003;16:259-265.
3. Giuliani F, Yong VW. Immune-mediated neurodegeneration and neuroprotection in MS. Int MS J. 2003;10:122-130.
4. Kornek B, Storch MK, Weissert R, et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol. 2000;157:267-276.
5. Petzold A, Rejdak K, Plant GT. Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry. 2004; 75:1178-1180.
6. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 2003;206:165-171.
7. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis [see comments]. N Engl J Med. 1998;338:278-285.
8. Hobom M, Storch MK, Weissert R, et al. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004;14:148-157.
9. 2 and extravasated serum albumin. Invest Ophthalmol Vis Sci. 1994;35:1114-1123.
10. Guy J, Ellis EA, Mames R, et al. Role of hydrogen peroxide in experimental optic neuritis: a serial quantitative ultrastructural study. Ophthalmic Res. 1993;25:253-264.
11. Lieven CJ, Hoegger MJ, Schlieve CR, et al. Retinal ganglion cell axotomy induces an increase in intracellular superoxide anion. Invest Ophthalmol Vis Sci. 2006;47:1477-1485.
12. Kalman B, Leist TP. A mitochondrial component of neurodegeneration in multiple sclerosis. Neuromol Med. 2003;3:147-158.
13. Cowden WB, Cullen FA, Staykova MA, et al. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol. 1998;88:1-8.
14. Ruuls SR, Van Der LS, Sontrop K, et al. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol. 1996;103: 467-474.
15. Mohamed A, Shoker A, Bendjelloul F, et al. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum. 2003;39:440-445.
16. Mohamed AA, Avila JG, Schultke E, et al. Amelioration of experimental allergic encephalitis (EAE) through phase 2 enzyme induction. Biomed Sci Instrum. 2002;38:9-13.
17. Spitsin SV, Scott GS, Mikheeva T, et al. Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med. 2002;33:1363-1371.
18. Hauswirth WW, Lewin AS, Zolotukhin S, et al. Production and purification of recombinant adeno-associated virus. Methods Enzymol. 2000;316:743-761.
19. Charles I, Khalyfa A, Kumar DM, et al. Serum deprivation induces apoptotic cell death of transformed rat retinal ganglion cells via mitochondrial signaling pathways. Invest Ophthalmol Vis Sci. 2005;46:1330-1338.
20. Fernandez-Vizarra E, Lopez-Perez MJ, Enriquez JA. Isolation of biogenetically competent mitochondria from mammalian tissues and cultured cells. Methods. 2002;26:292-297.
21. Maatta JA, Nygardas PT, Hinkkanen AE. Enhancement of experimental autoimmune encephalomyelitis severity by ultrasound emulsification of antigen/adjuvant in distinct strains of mice. Scand J Immunol. 2000;51:87-90.
22. Guy J, Qi X, Hauswirth WW. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA. 1998;95:13847-13852.
23. van der Laan LJ, Ruuls SR, Weber KS, et al. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol. 1996;70:145-152.
24. Lieven CJ, Vrabec JP, Levin LA. The effects of oxidative stress on mitochondrial transmembrane potential in retinal ganglion cells. Antioxid Redox Signal. 2003;5:641-646.
25. Bolanos JP, Almeida A, Stewart V, et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem. 1997;68:2227-2240.
26. Brookes PS, Bolanos JP, Heales SJ. The assumption that nitric oxide inhibits mitochondrial ATP synthesis is correct. FEBS Lett. 1999; 446:261-263.
27. Brookes PS, Land JM, Clark JB, et al. Peroxynitrite and brain mitochondria: evidence for increased proton leak. J Neurochem. 1998;70:2195-2202.
28. Hu P, Pollard J, Hunt N, et al. Microvascular and cellular responses in the optic nerve of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol. 1998;8:475-486.
29. Qi X, Lewin AS, Hauswirth WW, et al. Optic neuropathy induced by reductions in mitochondrial superoxide dismutase. Invest Ophthalmol Vis Sci. 2003;44:1088-1096.
30. Dutta R, McDonough J, Yin X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol. 2006;59:478-489.
31. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58:383-391.
32. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998; 281:1309-1312.
33. Vrabec JP, Lieven CJ, Levin LA. Cell-type-specific opening of the retinal ganglion cell mitochondrial permeability transition pore. Invest Ophthalmol Vis Sci. 2003;44:2774-2782.
34. Banisor I, Kalman B. Bcl-2 and its homologues in the brain of patients with multiple sclerosis. Mult Scler. 2004;10:176-181.
35. Pitkanen S, Robinson BH. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest. 1996;98:345-351.
36. Lu F, Selak M, O'Connor J, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177:95-103.
37. Vyshkina T, Banisor I, Shugart YY, et al. Genetic variants of complex I in multiple sclerosis. J Neurol Sci. 2005;228:55-64.
38. Tajouri L, Mellick AS, Ashton KJ, et al. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res. 2003;119: 170-183.
39. Qi X, Lewin AS, Sun L, et al. Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem. 2006;281:31950-31962.
40. Murray J, Taylor SW, Zhang B, et al. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem. 2003;278:37223-37230.
41. Qi X, Guy J, Nick H, et al. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis. Invest Ophthalmol Vis Sci. 1997;38:1203-1212.
42. Lim ET, Sellebjerg F, Jensen CV, et al. Acute axonal damage predicts clinical outcome in patients with multiple sclerosis. Mult Scler. 2005;11:532-536.
43. Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis: the Optic Neuritis Study Group [see comments]. N Engl J Med. 1992;326:581-588.
44. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963-969.
45. Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol. 2004;137:77-83.
46. Noseworthy JH, O'Brien PC, Petterson TM, et al. A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology. 2001;56:1514-1522.
47. Hickman SJ, Brierley CM, Brex PA, et al. Continuing optic nerve atrophy following optic neuritis: a serial MRI study. Mult Scler. 2002;8:339-342.
48. Hickman SJ, Kapoor R, Jones SJ, et al. Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J Neurol Neurosurg Psychiatry. 2003;74:1139-1141.
49. Barron MJ, Griffiths P, Turnbull DM, et al. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol. 2004;88:286-290.
50. Farkas RH, Qian J, Goldberg JL, et al. Gene expression profiling of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004;45:2503-2513.
51. Gass A, Moseley IF, Barker GJ, et al. Lesion discrimination in optic neuritis using high-resolution fat- suppressed fast spin-echo MRI. Neuroradiology. 1996;38:317-321.
52. Thorpe JW, Kidd D, Moseley IF, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology. 1996;46:373-378.
53. Kidd D, Thorpe JW, Kendall BE, et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996;60:15-19.